This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Martyn Frank Burslem: Innovator in Genetic Modulation
Introduction
Martyn Frank Burslem is a notable inventor based in the County of Kent, GB. He has made significant contributions to the field of genetic engineering, particularly in the modulation of PDE11A activity. His work has implications for understanding spermatogenesis and related biological processes.
Latest Patents
Martyn holds a patent for the invention titled "Modulation of PDE11A activity." This invention provides genetically-modified non-human mammals and genetically-modified animal cells that contain a functionally disrupted PDE11A gene. The patent also outlines methods for screening agents that modulate PDE11A to influence spermatogenesis, as well as methods for treating mammals to achieve similar modulation. Additionally, it includes techniques for modulating cAMP and cGMP signal transduction in cells expressing PDE11A.
Career Highlights
Martyn is associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to explore innovative solutions in genetic modulation and its applications in medicine. His research is pivotal in advancing our understanding of genetic influences on reproductive health.
Collaborations
Martyn has collaborated with notable colleagues, including Ian Dennis Harrow and Jeremy Lanfear. These partnerships have fostered a collaborative environment that enhances research and innovation in their respective fields.
Conclusion
Martyn Frank Burslem is a distinguished inventor whose work in genetic modulation has the potential to impact various biological and medical fields. His contributions to the understanding of PDE11A activity are invaluable, and his association with Pfizer Corporation further underscores his commitment to innovation.